Jan Nolta Capricor
Jan Nolta/blog.cirm.ca.gov

Jan Nolta: Capricor Therapeutics Announces Positive Results from Phase 3 HOPE-3 Study

Jan Nolta, Professor, Director of the Stem Cell Program and Gene Therapy Center at University of California, Davis, shared a post on LinkedIn:

“Congratulations to Capricor, PI Dr. Craig McDonald of University of California, Davis Health and his team, and to the patients and families for these exciting results. Thank you to our California Institute for Regenerative Medicine (CIRM) – funded Alpha Clinic for assisting with the trial logistics and product formulation and delivery.”

Read More about Cell Therapy on OncoDaily.